Oric Pharmaceuticals Inc
(ORIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,715 | -55,944 | -37,518 | -16,509 | -73,703 |
| Depreciation Amortization | 2,246 | 1,869 | 1,321 | 670 | 1,269 |
| Other Working Capital | 4,073 | 1,462 | -878 | -1,806 | 2,045 |
| Other Operating Activity | 12,855 | 9,356 | 5,960 | 2,744 | 25,121 |
| Operating Cash Flow | $-59,541 | $-43,257 | $-31,115 | $-14,901 | $-45,268 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 159,374 | 158,634 | 123,329 | 40,829 | -215,485 |
| PPE Investments | -939 | -550 | -317 | -182 | -667 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 193 |
| Investing Cash Flow | $158,435 | $158,084 | $123,012 | $40,647 | $-215,959 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50,986 | 50,173 | 74 | 16 | 271,751 |
| Other Financing Activity | -1,852 | -1,852 | -339 | 0 | -21,237 |
| Financing Cash Flow | $49,134 | $48,321 | $-265 | $16 | $250,514 |
| Beginning Cash Position | 78,446 | 78,446 | 78,446 | 78,446 | 89,159 |
| End Cash Position | 226,474 | 241,594 | 170,078 | 104,208 | 78,446 |
| Net Cash Flow | $148,028 | $163,148 | $91,632 | $25,762 | $-10,713 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,541 | -43,257 | -31,115 | -14,901 | -45,268 |
| Capital Expenditure | -939 | -550 | -317 | -182 | -667 |
| Free Cash Flow | -60,480 | -43,807 | -31,432 | -15,083 | -45,935 |